WallStreetZenWallStreetZen

NASDAQ: ORMP
Oramed Pharmaceuticals Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

ORMP past revenue growth

How has ORMP's revenue growth performed historically?
Company
-100%
Industry
76.88%
Market
16.68%
ORMP's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ORMP's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ORMP's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ORMP earnings and revenue history

Current Revenue
$0.0
Current Earnings
$20.9M
Current Profit Margin
0%

ORMP Return on Equity

Current Company
12.7%
Current Industry
23.1%
Current Market
34.1%
ORMP's Return on Equity (12.7%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ORMP announces earnings.

ORMP Return on Assets

Current Company
9.9%
Current Industry
3.6%
ORMP is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ORMP Return on Capital Employed

Current Company
5.62%
Current Industry
21.5%

ORMP vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ORMP$0.00$10.36M$20.86M-100.00%N/A
CTXR$0.00-$37.51M-$39.77MN/AN/A
RGLS$0.00-$34.70M-$35.39M-100.00%N/A
VSTM$10.00M-$85.14M-$89.49M-14.21%N/A
GNLX$8.00k-$26.13M-$26.54M-99.93%N/A
View Top Biotech Stocks

ORMP earnings dates

Next earnings date
Nov 7, 2024

Oramed Pharmaceuticals Earnings & Revenue FAQ

What were ORMP's earnings last quarter?

On Invalid Date, Oramed Pharmaceuticals (NASDAQ: ORMP) reported Q2 2024 earnings per share (EPS) of $0.22, up 833.33% year over year. Total Oramed Pharmaceuticals earnings for the quarter were $9.21 million. In the same quarter last year, Oramed Pharmaceuticals's earnings per share (EPS) was -$0.03.

If you're new to stock investing, here's how to buy Oramed Pharmaceuticals stock.

What was ORMP's earnings growth in the past year?

As of Q3 2024, Oramed Pharmaceuticals's earnings has grown year over year. Oramed Pharmaceuticals's earnings in the past year totalled $20.86 million.

What is ORMP's earnings date?

Oramed Pharmaceuticals's earnings date is Invalid Date. Add ORMP to your watchlist to be reminded of ORMP's next earnings announcement.

What was ORMP's revenue last quarter?

On Invalid Date, Oramed Pharmaceuticals (NASDAQ: ORMP) reported Q2 2024 revenue of $0.00 up 100% year over year. In the same quarter last year, Oramed Pharmaceuticals's revenue was $674.00 thousand.

What was ORMP's revenue growth in the past year?

As of Q3 2024, Oramed Pharmaceuticals's revenue has grown -100% year over year. This is 176.88 percentage points lower than the US Biotechnology industry revenue growth rate of 76.88%. Oramed Pharmaceuticals's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.